A sensitive restriction fragment length polymorphism method to detect CAA-->AAA mutations at codon 61 of Ha-ras
G A Shinder1, S Manam, W W Nichols
1Department of Safety Assessment, Merck Research Laboratories, West Point, Pennsylvania 19486.
Molecular Carcinogenesis
|January 1, 1993
Summary
This study presents a rapid and sensitive assay for detecting Ha-ras codon 61 mutations. The new method accurately identified mutations in mouse liver tumors, even in previously undetected cases.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The Ha-ras gene is frequently mutated in various cancers.
- Detecting specific mutations, like those at codon 61, is crucial for understanding cancer development.
- Existing methods for mutation detection can lack sensitivity or speed.
Purpose of the Study:
- To develop a rapid and highly sensitive assay for detecting CAA to AAA mutations at codon 61 of the Ha-ras gene.
- To validate the assay's performance using DNA from spontaneous mouse liver tumors.
- To compare the assay's detection capabilities against established sequencing methods.
Main Methods:
- Polymerase chain reaction (PCR) amplification of the Ha-ras codon 61 region using a primer with a mismatch.
- Introduction of an MseI restriction enzyme site upon specific mutation presence.
- 5'-end-labeling of PCR primers with 32P for enhanced sensitivity.
- DNA cleavage with MseI, electrophoresis on nondenaturing polyacrylamide gel, and autoradiography for visualization.
Main Results:
- The assay demonstrated high sensitivity, detecting mutations present in as little as one in 200 alleles.
- Analysis of 38 spontaneous mouse liver tumor samples revealed mutations in nine samples.
- The assay successfully identified a mutation in one sample that was missed by both direct sequencing and transfected cell sequencing.
Conclusions:
- The developed PCR-based assay is a rapid, sensitive, and effective tool for detecting Ha-ras codon 61 mutations.
- This method offers improved detection capabilities compared to traditional sequencing techniques, particularly for low-frequency mutations.
- The assay has significant potential for application in cancer research and diagnostics, especially in analyzing tumor samples.
Related Concept Videos
RACE - Rapid Amplification of cDNA Ends
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific primer.
Since the...
Since the...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...


